免疫疗法
基质金属蛋白酶
细菌外膜
阿霉素
癌症研究
肿瘤微环境
小泡
化学
免疫系统
医学
化疗
免疫学
膜
内科学
生物化学
基因
大肠杆菌
作者
Shuping Li,Xin Li,Jiaqi Meng,Weier Bao,Shuang Wang,Peng Ye,Xiao‐Dong Gao,Wei Wei
出处
期刊:Nano Research
[Springer Science+Business Media]
日期:2023-11-17
卷期号:17 (2): 836-847
被引量:17
标识
DOI:10.1007/s12274-023-6225-6
摘要
Bacterial outer membrane vesicles (OMVs) are potent immunostimulants of regulating the tumor microenvironment (TME) for immunotherapy, and can be used to deliver drugs. However, the severe systemic inflammatory response triggered by OMVs upon intravenous (i.v.) injection has limited their application. Here, we developed a safe and effective strategy by conjugating doxorubicin-loaded serum albumin (SA-DOX, AD) onto the surface of OMVs using a matrix metalloproteinase (MMP)-cleavable peptide linker (cL). This approach enabled the dynamic shielding of OMVs to reduce the systemic side effects while simultaneously enhancing the anti-tumor effects through chemo-immunotherapy. Specifically, the resulting OMV-cL-AD formulation exhibited significantly enhanced accumulation at the tumor site after i.v. administration, facilitated by the SA decoration on the OMVs surface. Subsequently, the shield on the OMV-cL-AD was cleaved by the over-expressed MMP in the TME, leading to the release of both OMVs and AD. This process provided OMV-induced immunotherapy and DOX-induced chemotherapy, resulting in synergistic tumor inhibition. In conclusion, our work demonstrated the potential of OMV-cL-AD as an effective immunochemotherapy strategy that can prolong the survival time of mice without inducing side effects.
科研通智能强力驱动
Strongly Powered by AbleSci AI